On the contrary, it has been demonstrated that 17-AAG treatment successfully suppresses neurodegeneration in a Drosophila model of SCA3 and HD, and it is the most effective agent among other HSF1-activating compounds in suppressing polyQ-related neurodegeneration in Drosophila models [79]. The gene discussed is HSF1; the disease is Huntington disease.